These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2186325)
1. [Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma]. Ludwig H; Fritz E; Kotzmann H; Gisslinger H Onkologie; 1990 Feb; 13(1):46-9. PubMed ID: 2186325 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin treatment of anemia associated with multiple myeloma. Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535 [TBL] [Abstract][Full Text] [Related]
3. [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin]. Ciepłuch H; Zaucha JM; Lysiak-Szydłowska W; Hellmann A Pol Arch Med Wewn; 1995 Aug; 94(2):153-8. PubMed ID: 8596750 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498 [TBL] [Abstract][Full Text] [Related]
5. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)]. Qiao ZH Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient]. Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222 [TBL] [Abstract][Full Text] [Related]
7. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin]. Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease. Holley JL; Nolan TA; Piraino B Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease]. Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin and the anemia of multiple myeloma. Barlogie B; Beck T Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789 [TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure]. Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064 [TBL] [Abstract][Full Text] [Related]
12. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia. Matsui H; Shiraishi N; Yasuda T; Nezuka T Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035 [TBL] [Abstract][Full Text] [Related]
13. Increase of bone marrow cellularity during erythropoietin treatment in myeloma. Ludwig H; Chott A; Fritz E; Krainer M Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma. Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Henry DH; Abels RI Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722 [TBL] [Abstract][Full Text] [Related]
16. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma]. Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713 [TBL] [Abstract][Full Text] [Related]
17. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ludwig H; Fritz E; Leitgeb C; Krainer M; Kührer I; Sagaster P; Umek H Ann Oncol; 1993 Feb; 4(2):161-7. PubMed ID: 8448084 [TBL] [Abstract][Full Text] [Related]
19. Anemia in multiple myeloma. Ludwig H; Pohl G; Osterborg A Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo. Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]